Issued Patents 2020
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10870855 | Use of MIR101 or MIR128 in the treatment of seizure disorders | — | 2020-12-22 |
| 10813918 | Use of Gaboxadol in the treatment of diabetes and related conditions | — | 2020-10-27 |
| 10813899 | Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders | Brett Abrahams | 2020-10-27 |
| 10799485 | Methods and compositions for treatment of epileptic disorders | — | 2020-10-13 |
| 10765666 | Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering | — | 2020-09-08 |
| 10765646 | Methods of treating developmental encephalopathies | — | 2020-09-08 |
| 10736894 | Methods of treating developmental syndromes with PDE10A inhibitors | — | 2020-08-11 |
| 10704048 | Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome | — | 2020-07-07 |
| 10653652 | Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction | — | 2020-05-19 |
| 10603308 | Methods and compositions for treatment of epileptic disorders | — | 2020-03-31 |